Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multicenter randomized double-blind Phase 3 trial of eberconazole 1% solution versus placebo in dermatophytosis
2005-001239-32Phase 3Completed
- Sponsor
- Laboratorios Salvat
- Start
- Jul 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in dermatophytosis comparing Eberconazole 1% solution with Placebo solution (2 arms). Primary endpoint: Primary efficacy endpoint. Started Jul 2005; status: completed.
02
Drugs
eberconazole
03
Conditions
dermatophytosis
Beyond the preview
Go deeper on 2005-001239-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001239-32.